PROS1 and infection: Our data suggests that expansion of non-RBD-specific B cells does not hinder development of broad neutralization potency against Omicron subvariants, while elicitation of non-neutralizing antibodies against the conserved epitopes of the S protein can contribute to mitigating infection or severe disease through Fc receptor functions44,72,73, particularly in the face of rapid viral evolution.